Multiple outlets report on new research examining the cardiovascular risks associated with polyendocrine metabolic ovarian syndrome (PMOS), a condition formerly referred to as PCOS. The studies find that women with PMOS have a substantially higher likelihood of cardiovascular disease than women without the condition. The Independent reports that women with PMOS face about four times higher risk of heart disease. ABC Australia similarly describes the risk as “significantly higher,” citing increased cardiovascular disease risk and specifically mentioning higher risk of heart attack and stroke. Other coverage notes the name change to PMOS, indicating the condition is widely recognized under both terms depending on source, while the underlying clinical condition remains the focus. Across reports, the shared message is that PMOS is associated with elevated cardiovascular risk, based on the findings of the referenced new study. The articles do not agree on additional specifics such as absolute risk figures, the study’s size, or whether the research establishes causation versus association, but they consistently attribute increased heart disease and related cardiovascular outcomes to the presence of PMOS.